Home
About
Overview
Sharing Data
ORCID
Help
History (13)
Prime Editing: A Novel Cas9-Reverse Transcriptase Fusion May Revolutionize Genome Editing.
Comparative Analysis of the Capsid Structures of AAVrh.10, AAVrh.39, and AAV8.
Venules
CX3C Chemokine Receptor 1
AAV-Mediated Gene Therapy for Glycosphingolipid Biosynthesis Deficiencies.
See All 13 Pages
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
AAV-Mediated Gene Therapy for Glycosphingolipid Biosynthesis Deficiencies.
Yang H, Brown RH, Wang D, Strauss KA, Gao G. AAV-Mediated Gene Therapy for Glycosphingolipid Biosynthesis Deficiencies. Trends Mol Med. 2021 06; 27(6):520-523.
View in:
PubMed
subject areas
Dependovirus
Epilepsy
Genetic Therapy
Genetic Vectors
Hereditary Sensory and Autonomic Neuropathies
Humans
Phenotype
Recombinant Proteins
Sialyltransferases
Spastic Paraplegia, Hereditary
authors with profiles
Dan Wang PhD
Kevin Strauss MD
Robert H Brown MD, DPhil
Guangping Gao PhD